Haley N Janowitz (Haley Janowitz)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Intensive Care Unit

Top Venues

Annals of neurology

This page only lists publications with an associated author ORCID identifier.

Publications

Haley N Janowitz, David J Linden
Chronic Treatment with Serotonin Selective Reuptake Inhibitors Does Not Affect Regrowth of Serotonin Axons Following Amphetamine Injury in the Mouse Forebrain. eNeuro 11 (2) (2024)
Haley N Janowitz, David J Linden
Chronic Treatment with Serotonin Selective Reuptake Inhibitors Does Not Affect Regrowth of Serotonin Axons Following Amphetamine Injury in the Mouse Forebrain. eNeuro 11 (2) (2024)
Haley N Janowitz, David J Linden
Chronic Treatment with Serotonin Selective Reuptake Inhibitors Does Not Affect Regrowth of Serotonin Axons Following Amphetamine Injury in the Mouse Forebrain. eNeuro 11 (2) (2024)
Céline Boileau, Severine Deforges, Angélique Peret, Didier Scavarda, Fabrice Bartolomei, April Giles, Nicolas Partouche, Justine Gautron, Julio Viotti, Haley N Janowitz, Guillaume Penchet, Cécile Marchal, Stanislas Lagarde, Agnès Trebuchon, Nathalie Villeneuve, Julie Rumi, Thomas Marissal, Roustem Khazipov, Ilgam Khalilov, Fanny Martineau, Marine Maréchal, Anne Lepine, Mathieu Milh, Dominique Figarella-Branger, Etienne Dougy, Soutsakhone Tong, Romain Appay, Stéphane Baudouin, Andrew Mercer, Jared B Smith, Olivier Danos, Richard Porter, Christophe Mulle, Valérie Crépel
GluK2 is a target for gene therapy in drug-resistant Temporal Lobe Epilepsy. Annals of neurology (2023)